Open Course 2016
Medical Industry Innovation Forum
The 2016 forum is over.
[Theme] Question the true value of the medical industry during a period business (model) transformation
Dates
November 29th, 2016 – February 21st ,2017 (6 sessions)
18:00 – 21:00 (Reception will be held after the lecture)
Location
Tetsumon Memorial Hall
(14th Floor, Faculty of Medicine Experimental Research Building)
Target Audience
200 people
- Undergraduate and graduate students (from The University of Tokyo and other universities)
- Medical Innovation Industry Institute members
- Healthcare professionals from medical institutes, academic societies, industries including pharmaceutical and medical device companies
- Other professionals with a strong interest in leading Innovation in the medical industry
Registration Fee
Please pay the fee via a single bank transfer payment. We will provide the account information at a later date
- Regular: 30,000JPY
- Mi3 Member: 15,000JPY (It costs extra, annual membership fee 12,000 yen)
- Student: Free, for 6 lectures.
Course Description
The rules of health care providers are changing. With the intervention of IT and AI in all fields, the value of information in the medical services and the ‘last mile’ for patient access is changing. Moreover, what is provided in the medical setting is changing, e.g. cell therapy, genome-based Precision Medicine, information available through the i-Appli. With regard to the existing medical care regimes, drug pricing rules are being actively discussed. The rules are being transformed by technology advances, and the business “fields” need to adapt and evolve to reflect the opportunities created.
In this year’s Medical Industry Innovation Forum, we will address the key industry dynamics through panel discussions and interaction. We will draw out what ‘survival of the fittest strategy’ is envisaged by each stakeholder in this period of fundamental transformation.
Contact Information
Forum office within Medical Innovation Industry Institute
Tel: +81-3-5842-3363
Presented by Pharmaco-Business Innovation, Graduate School of Pharmaceutical Sciences, the University of Tokyo (Professor: Hiromichi Kimura).
The Forum is sponsored by the Medical Innovation Industry Institute
Program
Nov.29th（Tue）
Shin-ichi Muramatsu
Jichi Medical University
Professor
Division of Oriental Medicine, Center for Community Medicine Division of Neurology, Department of Medicine
Yasushi Okuno
Kyoto University
Professor
Department of Biomedical Data Intelligence
Graduate School of Medicine
Masahiro Morimoto
FRONTEO, Inc.
CEO and Chairman of the Board
Hiromichi Kimura
The University of Tokyo
Visiting Professorr
Dec.13th（Tue）
Masanori Akita
MTI Ltd.
Senior General Manager
Healthcare Business Group
Yo Iwami
MedPeer,Inc.
President (M.D, Ph.D)
Kohei Yoshida
Ministry of Internal Affairs and Communications
Director, Information Applications Promotion Office, Information and Commiunications Bureau
Masaaki Matoba
Showa University Graduate School of Health Sciences
Assistant Professor
Jan. 24nd（Tue）
Toshikazu Ban
Fujifilm Corporation Corporate Vice President, General Manager, egenerative Medicine Business Div.
Cellular Dynamics International Japan Co.Ltd President
Yoji Sato
National Institute of Health Sciences
Head
Division of Cell-Based Therapeutic Products
Jun Takahashi
Kyoto University Professor
Center for iPS Cell Research and Application (CiRA)
Shintaro Sengoku
Tokyo Institute of Technology
Assistant Professor
Department of Innovation Science, School of Environment and Society
Jan.31th（Tue）
Yoshiyuki Majima
PANCREATIC CANCER ACTION NETWORK
Japan Federation of Cancer Patient Groups
Toshiaki Sai
Daiichi Sankyo Co., Ltd.
Member of the Board
Senior Executive Officer, Head of Corporate Strategy Division
Masami Sakoi
Ministry of Health, Labour and Welfare Government of JAPAN
Director, Medical Economics Division Health Insurance Bureau
Hiromichi Kimura
The University of Tokyo
Visiting Professorr
Feb.7th（Tue）
Kaoru Asano
SYSMEX CORPORATION
Member of the Managing Board and Senior Executive Officer
Managing Director
Soichiro Isobe
Ministry of Health, Labor and Welfare Director
Medical Device Evaluation Division
Pharmaceutical Safety and Environmental Health Bureau
Takahiro Ochiya
National Cancer Center Research Institute
Group for Research of Molecular Functions and Targets Chief, Division of Molecular and Cellular Medicine
Sumimasa Nagai
The University of Tokyo Senior Assistant Professor
Division of Genetic Therapeutics, The dvanced Clinical Research Center
Center for Translational Research and Department of Hematology/Oncology, Research Hospital
The Institute of Medical Science
Feb. 21st（Tue）
Suguru Roy Kimura
S. Roy Kimura, Ph.D., Founder and Representative Director, Modulus Discovery, Inc.
Associate Professor, Industry Youth Mentor, Special Appointment, Tokyo Institute of Technology Education Academy of Computational Life Sciences
Yutaka Akiyama
Tokyo Institute of Technology
Professor, School of Computing,
Director, Education Academy of Computational Life Sciences
Keiichi Masuya
PeptiDream Inc.
Vice President, Head of Chemistry
Member Board of Directors
Kazuki Ohno
Catalyst, inc. President
Tokyo Institute of Technology
Associate Professor (Industry Youth Mentor)Education Academy of Computational Life Sciences